| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | Zalevsky Jonathan Chief R&D Officer | Sale | -199 | -0.94%20,975 | $65.51 | $13,036 | View SEC filing | |
| 2026-05-21 | ROBIN HOWARD W President & CEO | Sale | -444 | -0.59%75,045 | $65.51 | $29,086 | View SEC filing | |
| 2026-02-20 | Zalevsky Jonathan Chief R&D Officer | Sale | -180 | -0.84%21,174 | $73.00 | $13,140 | View SEC filing | |
| 2026-02-20 | ROBIN HOWARD W President & CEO | Sale | -423 | -0.56%75,489 | $73.00 | $30,879 | View SEC filing | |
| 2026-01-22 | Zalevsky Jonathan Chief R&D Officer | Sale | -3,867 | -15.33%21,354 | $35.67 | $137,936 | View SEC filing | |
| 2025-11-25 | Zalevsky Jonathan Chief R&D Officer | Sale | -1,157 | -5.75%18,971 | $54.28 | $62,802 | View SEC filing | |
| 2025-11-25 | Wilson Mark Andrew Chief Legal Officer | Sale | -630 | -2.84%21,585 | $54.28 | $34,196 | View SEC filing | |
| 2025-11-25 | ROBIN HOWARD W President & CEO | Sale | -2,207 | -3.91%54,245 | $54.28 | $119,796 | View SEC filing | |
| 2025-09-11 | ROBIN HOWARD W President & CEO | Sale | -6,666 | -11.90%49,342 | $46.69 | $311,214 | View SEC filing | |
| 2025-09-08 | Zalevsky Jonathan Chief R&D Officer | Sale | -1,721 | -8.97%17,462 | $33.52 | $57,693 | View SEC filing | |
| 2025-09-08 | ROBIN HOWARD W President & CEO | Sale | -11,832 | -17.44%56,008 | $36.42 | $430,959 | View SEC filing | |
| 2025-09-04 | Zalevsky Jonathan Chief R&D Officer | Sale | -485 | -2.47%19,183 | $30.10 | $14,599 | View SEC filing | |
| 2025-09-04 | ROBIN HOWARD W President & CEO | Sale | -1,500 | -2.16%67,840 | $30.16 | $45,240 | View SEC filing | |
| 2025-08-21 | Zalevsky Jonathan Chief R&D Officer | Sale | -725 | -3.56%19,668 | $26.59 | $19,278 | View SEC filing | |
| 2025-08-21 | Wilson Mark Andrew Chief Legal Officer | Sale | -676 | -3.22%20,312 | $26.59 | $17,975 | View SEC filing | |
| 2025-08-21 | ROBIN HOWARD W President & CEO | Sale | -1,573 | -2.22%69,340 | $26.59 | $41,826 | View SEC filing | |
| 2025-05-21 | Zalevsky Jonathan Chief R&D Officer | Sale | -10,712 | -3.38%305,892 | $0.67 | $7,177 | View SEC filing | |
| 2025-05-21 | Wilson Mark Andrew Chief Legal Officer | Sale | -9,996 | -3.08%314,296 | $0.67 | $6,697 | View SEC filing | |
| 2025-05-21 | ROBIN HOWARD W President & CEO | Sale | -23,208 | -2.14%1,063,693 | $0.67 | $15,549 | View SEC filing | |
| 2025-02-21 | Zalevsky Jonathan Chief R&D Officer | Sale | -10,300 | -3.15%316,604 | $1.01 | $10,403 | View SEC filing | |
| 2025-02-21 | Wilson Mark Andrew Chief Legal Officer | Sale | -11,040 | -3.29%324,292 | $1.01 | $11,150 | View SEC filing | |
| 2025-02-21 | ROBIN HOWARD W President & CEO | Sale | -23,774 | -2.14%1,086,901 | $1.01 | $24,012 | View SEC filing | |
| 2024-12-26 | Wilson Mark Andrew Chief Legal Officer | Sale | -49,962 | -12.97%335,332 | $0.90 | $44,800 | View SEC filing | |
| 2024-12-20 | Zalevsky Jonathan Chief R&D Officer | Sale | -51,115 | -13.52%326,904 | $0.94 | $48,048 | View SEC filing | |
| 2024-12-19 | ROBIN HOWARD W President & CEO | Sale | -132,030 | -10.62%1,110,675 | $1.00 | $131,650 | View SEC filing |
1-25 of 443
